Vimarsana
Biggest News Aggregation in the World

Page 7 - Biomedical Catalyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Catalyst Today - Breaking & Trending Today

Innovate UK: New £7 million fund to help UK health-tech SMEs navigate regulations - Vimarsana News

Innovate UK: New £7 million fund to help UK health-tech SMEs navigate regulations

CPI and the Association of British HealthTech Industries (ABHI) have announced the Health Technology Regulatory and Innovation Programme, funded by Innovate UK. CPI is part of the High-Value Manufacturing Catapult. This joint initiative with ABHI will help small and medium-sized HealthTech companies to navigate the HealthTech regulatory processes. The UK has a vibrant and rapidly-growing HealthTech sector, supplying a variety of products such as:

Roundup: Malaffi supports Abu Dhabi COVID-19 vaccination campaign, Vodafone pilots 5G at Welsh hospital and more briefs - Vimarsana News

Roundup: Malaffi supports Abu Dhabi COVID-19 vaccination campaign, Vodafone pilots 5G at Welsh hospital and more briefs

PROXIMIE COMPLETES PILOTS WITH VODAFONE 5G AT WELSH HOSPITAL London-based health technology company focused on digitising operating rooms, Proximie, has partnered with Vodafone to pilot the use of 5G in the areas of remote assistance and training in cancer care. The first successful pilots took place in University Hospital of Wales and University Hospital Llandough last week. Proximie's platform enables clinicians to virtually transport themselves into operating rooms, cath labs and hospitals to visually interact, engage and guide procedures. The platform combines human expertise with augment...

Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update - Vimarsana News

Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

Bicycle Therapeutics plc: Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update BT7480, the lead Bicycle tumor-targeted immune cell agonist, presented at AACR Annual Meeting 2021 "New Drugs on the Horizon" session; remains on-track for 2H'21 clinical trial start Achieved significant recent progress across pipeline of Bicycle -based therapies beyond oncology Raised $75.0 million through at-the-market offering program; cash of $195.9 million as of March 31, 2021 expected to provide financial runway through multiple clinical milestones and into 2024 Bic...